Cargando…
An Off-Label Use of a Unibody Aortic Stent-Graft System for the Treatment of Infrarenal Abdominal Aortic Dissections
Infrarenal abdominal aortic dissections (IAAD) are exceedingly rare, accounting for 1-4% of all aortic dissections. The evidence is scarce on how to best manage IAAD when they become symptomatic. Two main interventional approaches exist, open surgery and the endovascular approach. Conventional stent...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6476008/ https://www.ncbi.nlm.nih.gov/pubmed/31093417 http://dx.doi.org/10.1155/2019/6853135 |
_version_ | 1783412830560583680 |
---|---|
author | Faraj, Joseph Tan, Rebekah L. W. Mwipatayi, Bibombe P. |
author_facet | Faraj, Joseph Tan, Rebekah L. W. Mwipatayi, Bibombe P. |
author_sort | Faraj, Joseph |
collection | PubMed |
description | Infrarenal abdominal aortic dissections (IAAD) are exceedingly rare, accounting for 1-4% of all aortic dissections. The evidence is scarce on how to best manage IAAD when they become symptomatic. Two main interventional approaches exist, open surgery and the endovascular approach. Conventional stent-graft systems make it difficult to treat nonaneurysmal aortic disease due to limb competition in a narrow distal aorta. Thus, we present a novel use of the Endologix Anatomical Fixation 2 (AFX2) Abdominal Aortic Aneurysm (AAA) endograft system for the treatment of four patients with IAAD. We also highlight an individual case study that was treated with an alternative endovascular approach and the complications that followed. This was to highlight and compare our successful experience with Endologix AFX2 AAA endograft system. There were multiple benefits for choosing this stent-graft; however the main advantage is its suitability in the narrow distal aorta. Our aim was to highlight an alternative endovascular approach for the successful treatment of a rare, challenging, and potentially fatal pathology. |
format | Online Article Text |
id | pubmed-6476008 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Hindawi |
record_format | MEDLINE/PubMed |
spelling | pubmed-64760082019-05-15 An Off-Label Use of a Unibody Aortic Stent-Graft System for the Treatment of Infrarenal Abdominal Aortic Dissections Faraj, Joseph Tan, Rebekah L. W. Mwipatayi, Bibombe P. Case Rep Vasc Med Case Report Infrarenal abdominal aortic dissections (IAAD) are exceedingly rare, accounting for 1-4% of all aortic dissections. The evidence is scarce on how to best manage IAAD when they become symptomatic. Two main interventional approaches exist, open surgery and the endovascular approach. Conventional stent-graft systems make it difficult to treat nonaneurysmal aortic disease due to limb competition in a narrow distal aorta. Thus, we present a novel use of the Endologix Anatomical Fixation 2 (AFX2) Abdominal Aortic Aneurysm (AAA) endograft system for the treatment of four patients with IAAD. We also highlight an individual case study that was treated with an alternative endovascular approach and the complications that followed. This was to highlight and compare our successful experience with Endologix AFX2 AAA endograft system. There were multiple benefits for choosing this stent-graft; however the main advantage is its suitability in the narrow distal aorta. Our aim was to highlight an alternative endovascular approach for the successful treatment of a rare, challenging, and potentially fatal pathology. Hindawi 2019-04-08 /pmc/articles/PMC6476008/ /pubmed/31093417 http://dx.doi.org/10.1155/2019/6853135 Text en Copyright © 2019 Joseph Faraj et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Case Report Faraj, Joseph Tan, Rebekah L. W. Mwipatayi, Bibombe P. An Off-Label Use of a Unibody Aortic Stent-Graft System for the Treatment of Infrarenal Abdominal Aortic Dissections |
title | An Off-Label Use of a Unibody Aortic Stent-Graft System for the Treatment of Infrarenal Abdominal Aortic Dissections |
title_full | An Off-Label Use of a Unibody Aortic Stent-Graft System for the Treatment of Infrarenal Abdominal Aortic Dissections |
title_fullStr | An Off-Label Use of a Unibody Aortic Stent-Graft System for the Treatment of Infrarenal Abdominal Aortic Dissections |
title_full_unstemmed | An Off-Label Use of a Unibody Aortic Stent-Graft System for the Treatment of Infrarenal Abdominal Aortic Dissections |
title_short | An Off-Label Use of a Unibody Aortic Stent-Graft System for the Treatment of Infrarenal Abdominal Aortic Dissections |
title_sort | off-label use of a unibody aortic stent-graft system for the treatment of infrarenal abdominal aortic dissections |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6476008/ https://www.ncbi.nlm.nih.gov/pubmed/31093417 http://dx.doi.org/10.1155/2019/6853135 |
work_keys_str_mv | AT farajjoseph anofflabeluseofaunibodyaorticstentgraftsystemforthetreatmentofinfrarenalabdominalaorticdissections AT tanrebekahlw anofflabeluseofaunibodyaorticstentgraftsystemforthetreatmentofinfrarenalabdominalaorticdissections AT mwipatayibibombep anofflabeluseofaunibodyaorticstentgraftsystemforthetreatmentofinfrarenalabdominalaorticdissections AT farajjoseph offlabeluseofaunibodyaorticstentgraftsystemforthetreatmentofinfrarenalabdominalaorticdissections AT tanrebekahlw offlabeluseofaunibodyaorticstentgraftsystemforthetreatmentofinfrarenalabdominalaorticdissections AT mwipatayibibombep offlabeluseofaunibodyaorticstentgraftsystemforthetreatmentofinfrarenalabdominalaorticdissections |